|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows (used in) provided by: Operating activities: | |||||
| Net (loss) income | |||||
| Net (income) loss from discontinued operations | |||||
| Income from operations of discontinued operations, net of tax | |||||
| Gain on disposal of discontinued operations, net of tax | |||||
| (Loss) income from continuing operations | |||||
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||
| Impairment losses including inventory | |||||
| Depreciation and amortization | |||||
| Amortization of intangible assets | |||||
| Stock-based compensation expense | |||||
| Amortization of debt issuance costs and other non-cash interest expense | |||||
| Loss on remeasurement of equity interest | |||||
| (Gain) on remeasurement of equity interest | |||||
| Loss from early extinguishment of debt | |||||
| (Gain) loss on orbital receivables allowance | |||||
| Cumulative JUPITER3 adjustment | |||||
| Cumulative adjustment to SXM-7 revenue | |||||
| Impairment losses | |||||
| Deferred income tax expense (benefit) | |||||
| Equity in (income) loss from joint ventures, net of tax | |||||
| Loss (gain) on sale of assets | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Trade and other receivables, net | |||||
| Accounts payable and liabilities | |||||
| Contract liabilities | |||||
| Prepaid and other assets | |||||
| Other | |||||
| Cash provided by operating activities - continuing operations | |||||
| Cash used in operating activities - discontinued operations | |||||
| Cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchase of property, plant and equipment | |||||
| Purchase/development of intangible assets | |||||
| Purchase of property, plant and equipment and development or purchase of software | |||||
| Acquisitions, net of cash acquired | |||||
| Return of capital from discontinued operations | |||||
| Other | |||||
| Cash used in investing activities - continuing operations | |||||
| Cash provided by investing activities - discontinued operations | |||||
| Cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| Cash paid to extinguish existing Term Loan B | |||||
| Proceeds from amendment of Term Loan B, net of discount | |||||
| Repurchase of 9.75% 2023 Notes, including premium | |||||
| Proceeds from issuance of Notes | |||||
| 7.75% 2027 Notes | |||||
| 7.54% 2027 Notes | |||||
| Total proceeds from issuance of Notes | |||||
| Net proceeds from Revolving Credit Facility | |||||
| Debt issuance costs paid | |||||
| Settlement of securitization liability | |||||
| Repurchase of orbital receivables | |||||
| Repayments of long-term debt | |||||
| Other | |||||
| Cash provided by (used in) financing activities - continuing operations | |||||
| Cash used in financing activities - discontinued operations | |||||
| Cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of year | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
Loading...